RELAPSED/REFRACTORY

Clinical trials for RELAPSED/REFRACTORY explained in plain language.

Never miss a new study

Get alerted when new RELAPSED/REFRACTORY trials appear

Sign up with your email to follow new studies for RELAPSED/REFRACTORY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

Experimental CAR-T therapy takes on stubborn blood disorder

Disease control Not yet recruiting

This early-phase study tests a new treatment called IASO206 for people whose autoimmune hemolytic anemia (AIHA) has not responded to standard therapies. AIHA is a condition where the immune system mistakenly destroys red blood cells, causing fatigue and other symptoms. The study …

Matched conditions: RELAPSED/REFRACTORY

Phase: PHASE1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control

Last updated Jun 27, 2026 12:34 UTC

RELAPSED/REFRACTORY

Get alerted when new RELAPSED/REFRACTORY trials appear

Experimental CAR-T therapy takes on stubborn blood disorder